| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.17 | 0.3 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.3 | 0.3 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |